GNRX
VanEck Vectors Generic Drugs ETF
GNRX
GNRX
Delisted
GNRX was delisted on the 4th of April, 2019.
3 hedge funds and large institutions have $458K invested in VanEck Vectors Generic Drugs ETF in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$10.1K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$202K |
| 2 |
IA
IFP Advisors
Tampa,
Florida
|
-$51K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $354K | -$202K | -8,970 | -36% |
|
|
2
UBS Group
Zurich,
Switzerland
| $78K | +$10.1K | +445 | +15% |
|
|
FDCDDQ
3
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $25.9K | – | – | – |
|
|
IA
4
IFP Advisors
Tampa,
Florida
| – | -$51K | -2,250 | Closed |
|